The main aim of this cohort study based at Kaiser Permanente Northern California is to evaluate the impact of obesity on ovarian cancer treatment and survival, with consideration of disparities across the different racial/ethnic groups in these outcomes. This study is funded by the National Cancer Institute.
 

Study Team:

• Elisa V. Bandera, MD, PhD (Principal Investigator)
   
• Lawrence H. Kushi, ScD
   
• Valerie S. Lee
   
• Lorna Rodriguez-Rodriguez, MD, PhD
   
• Bethan Powell, MD

Publications:

• Bandera EV, Lee VS, Rodriguez-Rodriguez L, Powell CB, Kushi LH. Chemotherapy dosing and ovarian cancer survival according to body mass index.  JAMA Oncology 2015; 1(6):737-45.
   

• Bandera EV, Lee V, Rodriguez-Rodriguez L, Powell B, Kushi LH. Racial/ethnic disparities in ovarian cancer treatment and survival. Clinical Cancer Research 2016 Dec 1;22(23):5909-5914.

Under Review:

• Bandera, EV, Lee V, Qin B, Rodriguez-Rodriguez L, Powell B, Kushi LH. Impact of body mass index on ovarian cancer survival varies by stage.  (under review)